Inovio Pharmaceuticals(INO) - 2024 Q2 - Quarterly Results

Exhibit 99.1 INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights PLYMOUTH MEETING, PA – August 8, 2024 – INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced its financial results for the second quarter of 2024 and provided an update on recent company developments. "We continue to make progress with our lead candidate, IN ...